Gainers
Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.
Express's (NYSE:EXPR) short percent of float has fallen 10.74% since its last report. The company recently reported that it has 4.98 million shares sold short, which is 7.56% of all regular shares that are available for trading.
Express (NYSE:EXPR) reported its Q2 earnings results on Wednesday, August 31, 2022 at 06:45 AM.
Here's what investors need to know about the announcement.